Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Long-Term Treatment with the Once-Daily Oral Iron Chelator Deferasirox (Exjadereg], ICL670) Is Effective and Generally Well Tolerated in Pediatric Patients.

A. Piga, M. Bejaoui, Y. Kilinc, S. Perrotta, E. Vichinsky, C. Arrowsmith-Bensasson, E. Glimm, D. Alberti

Blood (2006) 108 (11): 1781.

https://doi.org/10.1182/blood.V108.11.1781.1781

Published: 2006

Journal Articles

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

Blood (2005) 106 (11): 2689.

https://doi.org/10.1182/blood.V106.11.2689.2689

Published: 2005

Journal Articles

Familial Pseudohyperkalemia Maps to the Same Locus as Dehydrated Hereditary Stomatocytosis (Hereditary Xerocytosis)

A. Iolascon, G.W. Stewart, J.F. Ajetunmobi, S. Perrotta, J. Delaunay, M. Carella, L. Zelante, P. Gasparini

Blood (1999) 93 (9): 3120–3123.

https://doi.org/10.1182/blood.V93.9.3120

Published: 1999

Journal Articles

UGT1 Promoter Polymorphism Accounts for Increased Neonatal Appearance of Hereditary Spherocytosis

A. Iolascon, M.F. Faienza, A. Moretti, S. Perrotta, E. Miraglia del Giudice

Blood (1998) 91 (3): 1093–1094.

https://doi.org/10.1182/blood.V91.3.1093

Published: 1998

Journal Articles

The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum

N Alloisio, P Texier, L Denoroy, C Berger, E Miraglia del Giudice, S Perrotta, A Iolascon, F Gilsanz, G Berger, J Guichard

Blood (1996) 87 (10): 4433–4439.

https://doi.org/10.1182/blood.V87.10.4433.bloodjournal87104433

Published: 1996

Journal Articles

Mild elliptocytosis associated with the alpha 34 Arg-->Trp mutation in spectrin Genova (alpha I/74)

S Perrotta, E Miraglia del Giudice, N Alloisio, G Sciarratta, L Pinto, J Delaunay, S Cutillo, A Iolascon

Blood (1994) 83 (11): 3346–3349.

https://doi.org/10.1182/blood.V83.11.3346.3346

Published: 1994

NARROW

Long-Term Treatment with the Once-Daily Oral Iron Chelator Deferasirox (Exjadereg], ICL670) Is Effective and Generally Well Tolerated in Pediatric Patients.

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

Familial Pseudohyperkalemia Maps to the Same Locus as Dehydrated Hereditary Stomatocytosis (Hereditary Xerocytosis)

UGT1 Promoter Polymorphism Accounts for Increased Neonatal Appearance of Hereditary Spherocytosis

The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum

Mild elliptocytosis associated with the alpha 34 Arg-->Trp mutation in spectrin Genova (alpha I/74)

Email alerts

ASH Publications

American Society of Hematology

Long-Term Treatment with the Once-Daily Oral Iron Chelator Deferasirox (Exjadereg], ICL670) Is Effective and Generally Well Tolerated in Pediatric Patients.

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

Familial Pseudohyperkalemia Maps to the Same Locus as Dehydrated Hereditary Stomatocytosis (Hereditary Xerocytosis)

UGT1 Promoter Polymorphism Accounts for Increased Neonatal Appearance of Hereditary Spherocytosis

The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum

Mild elliptocytosis associated with the alpha 34 Arg-->Trp mutation in spectrin Genova (alpha I/74)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only